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Abstract
For most complex traits we have a poor understanding of the positions, phenotypic effects, and 
population frequencies of the underlying genetic variants contributing to their variation. Recently, 
several groups have developed multi-parent advanced intercross mapping panels in different 
model organisms in an attempt to improve our ability to characterize causative genetic variants. 
These panels are powerful and are particularly well suited to the dissection of phenotypic variation 
generated by rare alleles and loci segregating multiple functional alleles. We describe studies 
using one such panel, the Drosophila Synthetic Population Resource, and the implications for our 
understanding of the genetic basis of complex traits. In particular, we note that many loci of large 
effect appear to be multiallelic. If multiallelism is a general rule, analytical approaches designed to 
identify multiallelic variants should be a priority for both genome wide association studies and 
multi-parental panels.
Keywords
Multi-parental Population; multiallelism; Drosophila melanogaster; complex traits; missing 
heritability
A Central Question in Biology
A striking feature of biology is that within populations there is a great deal of inter-
individual phenotypic variation. This is true for characters of economic importance in 
domesticated animals and plants (e.g., yield, growth rate, taste), evolutionary interest (e.g., 
ability to evade predators, traits influencing reproductive success), and medical relevance in 
humans (e.g., blood pressure, risk of heart disease, predisposition to schizophrenia). 
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Although variation in these complex traits is in part due to environmental differences 
experienced during development and growth, estimates of narrow sense heritability tell us 
that segregating genetic differences often contribute upwards of 50% to the total phenotypic 
variation [1,2]. Describing the molecular genetic architecture of complex trait variation is of 
central importance to biology. Do the most prominent genes contributing to variation in a 
complex trait explain a large or small fraction of the variation? Are causative genes 
generally biallelic or do they tend to harbor allelic series? Are causative polymorphic 
nucleotides generally rare or intermediate in frequency? How important are genotype-by-
environment or genotype-by-genotype (epistasis) interactions? Are causative sites generally 
amino acid polymorphisms, cis-regulatory variants, or some other molecular class of 
variation?
Despite the myriad of well-defined questions central to understanding complex trait 
variation, we have made only modest progress in empirically addressing them. Throughout 
the 1990s, the community attempted to dissect complex traits using QTL (Quantitative Trait 
Locus) mapping in the F1 offspring of a pair of inbred lines. By and large, the approach 
taken mimicked an experimental program laid out in two landmark papers, one describing a 
QTL mapping experiment in tomato [3] and a second describing the statistical machinery 
allowing for interval mapping of any complex trait given some dense set of genetic markers 
[4]. Once inexpensive PCR-based markers became widely available, QTL were mapped for 
hundreds of cross/character combinations. Experiments typically mapped a handful of QTL 
capable of explaining the bulk of genetic variation segregating in a cross, but failed to 
localize causative sites to intervals smaller than ∼10cM, typically too large to consider 
positional cloning. After the turn of the millennium, QTL mapping for the genetic dissection 
of trait variation was supplanted by genome-wide association studies (GWAS), initially 
driven by the commercial availability of arrays capable of genotyping hundreds of thousands 
of SNPs (Single Nucleotide Polymorphisms) relatively cost-effectively in humans. 
Association studies were not a new idea, but a key paper by the Welcome Trust Case 
Control Consortium that genotyped thousands of cases and controls for several important 
genetic diseases significantly altered the intellectual landscape [5]. Over the past decade 
hundreds of GWAS studies have been carried out in humans, and over 1000 replicable SNP-
phenotype associations have been detected [6]. A striking observation is that most SNPs 
significantly associated with complex trait variation in humans explain just a tiny fraction of 
the known heritable variation in that trait [7], and even associations identified in massive 
meta-analyses [8] only account for a small fraction of the heritability. The factors 
responsible for this missing heritability in outbred animal species remain elusive, but 
experiments with model systems represent a promising avenue for obtaining insight into 
these phenomena.
Multi-Parental Populations in Model Systems
A strategy that has been recently utilized for the dissection of complex traits in several 
model systems is the use of Multi-Parental Populations (MPPs). MPPs start with k highly-
inbred founder strains and through an n generation cross create individuals who are genetic 
mosaics of those founders (Figure 1). Initiating the MPPs from several founder strains 
greatly expands the number of natural haplotypes segregating at any given gene, providing a 
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more representative picture of standing variation within the species than mapping 
experiments initiated from only two founders. After several generations of intercrossing, 
individuals from a highly-recombinant, synthetic Fn population are then inbred via full-
sibling mating to yield Recombinant Inbred Lines (RILs). Multiple generations of 
intercrossing prior to RIL extraction reduces the expected size of founder chromosomal 
fragments, resulting in increased QTL mapping resolution. Advanced intercross resources 
are now available for several organisms, varying in the number of inbred founders, the 
crossing design, and the number of lines available for mapping (Table 1).
The populations from which MPPs are derived are synthetic in the sense that they are made 
by intercrossing a modest number of highly inbred and highly characterized founder strains. 
As such, the genetic architecture of these populations is not completely representative of 
variation segregating in the natural population from which the founder strains were obtained. 
The largest such distinction between synthetic and natural populations is the contribution of 
rare variants to standing variation. In natural populations rare variants as a class may make 
significant contributions to standing variation, but they are difficult to detect via any sort of 
association study scheme [9]. In contrast, in a synthetic population rare variants either fail to 
be sampled or are at a frequency of 1/k. Thus, they can be studied when sampled, but their 
contribution to standing variation is difficult to estimate since their frequency in the source 
population from which the founders are derived is unknown. Despite this limitation, by 
simultaneously examining several natural alleles at every gene, synthetic populations can 
elucidate general features of the genetic architecture of complex traits, and these features 
can guide future work in natural populations.
Strengths of MPPs for Complex Trait Dissection
Users of MPP RILs measure some complex trait of interest in the panel and statistically 
identify the most likely genomic position of genetic factors affecting the trait. There are key 
differences between GWAS and MPP frameworks that affect mapping resolution, the power 
to detect rare alleles, and the ability to identify multiallelic loci.
GWAS seek to detect associations between single biallelic SNPs and a phenotype measured 
in a panel (e.g., [5,10]). Because linkage disequilibrium (LD) in a population is likely to be 
modest, the hope is to genotype SNPs at a sufficiently high density that the causative SNP 
itself is among the genotyped set [11], or barring that is in strong LD with a genotyped site 
[9]. By contrast, in an MPP, at any given genomic location the statistical test carried out is 
analogous to a one-way ANOVA with levels corresponding to the k founder haplotypes. 
This testing approach is effective because if the advanced intercross lines are properly 
constructed, all but regions of the genome tightly linked to the locus being tested are 
randomized with respect to founder types. Unlike a GWAS that typically tests the effect of a 
SNP on a phenotype, an MPP tests the effect of a local haplotype a few cM in size on a 
phenotype, effectively integrating over all the causative variants in that gene region. The 
implication is that the estimated effects associated with the k founder types at any given 
location are the additive effects of those gene-size or larger alleles with respect to the 
remainder of the genome. The differences in statistical testing philosophies result in 
qualitatively different sets of possible inferences in GWAS and MPP frameworks.
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Molecular Nature of Functional Allelic Variation
One clear benefit of the MPP design is that it is agnostic as to the molecular nature of 
functional alleles underlying trait variation. GWAS rely on dense marker sets to ensure 
causative sites are either genotyped or indirectly targeted via strong LD with a genotyped 
marker. Currently this can only be achieved cost-effectively with SNP arrays [5] or Illumina 
resequencing [10,12], resulting in markers that tend to be biallelic SNPs or small INDELs. If 
causative changes represent other classes of molecular variation, such as repeats, large 
structural variants, transposable elements, and so on, these are only queried in a GWAS if 
they happen to be in strong LD with a genotyped SNP. Because the statistical test employed 
in an MPP is a haplotype-based test of an entire genomic region, the precise molecular 
nature of the causative allele has no effect on the ability of the experiment to identify it.
The downside is that an MPP is unable to localize an association to the precise molecular 
variant, thus association studies potentially offer higher resolution than those based on 
MPPs. Following mapping in an MPP, a 95% confident interval on the location of causative 
sites will typically encompass 0.5-5 Mb [13-17]. Thus localizing QTL to windows 
containing several (or several dozen) genes. By contrast, when a significant association is 
detected in a collection of natural chromosomes, the causative site is likely very close to the 
marker. Although resolution in an MPP is much higher than that achieved by traditional 
two-parent QTL mapping, resolution is a weakness of MPP resources compared to GWAS.
Rare Causative Loci
In a collection of natural chromosomes, SNPs can be at any frequency, with rare alleles 
dominating [18-20]. GWAS have modest power to identify intermediate-frequency 
causative variants provided the sample size is large. By contrast, if causative alleles happen 
to be rare (i.e., < 1-5%), as is likely to be the case under a mutation selection balance model 
[21,22], GWAS have very poor power. This is largely due to the poor power of statistical 
tests when groups being compared are of vastly unequal sample sizes. By contrast, provided 
a rare allele is sampled in the founders of an MPP, its frequency will often be fairly common 
in the mapping panel (with an expectation of 1/k). Thus, power to detect rare alleles in an 
MPP is fairly high, provided they are sampled [15]. Unfortunately, while MPPs sample a 
larger proportion of standing variation than two-parent QTL mapping, the actual fraction of 
segregating genetic variation captured is unknown.
Allelic Heterogeneity at Causative Loci
If a single gene harbors multiple rare causative variants in weak LD with one another, a 
GWAS is poorly powered to detect such variants, and such genes may be invisible to the 
GWAS approach. This scenario, of multiple causative biallelic variants at a single gene, is 
the architecture one expects to exist if the variation in a complex trait is maintained by 
recurrent deleterious mutations [21,22], and is exactly the pattern observed for single-gene, 
Mendelian diseases such as phenylketonuria. In a GWAS framework an individual 
association test must reach a strict statistical threshold to be declared significant. For a gene 
harboring multiple causative variants having low LD with one another, each individual 
variant will account for only a fraction of the variation accounted for by the entire gene, so 
GWAS power is reduced. A corollary is that under allelic heterogeneity GWAS will 
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underestimate the effect size of a gene, as it will tend to highlight only the largest effect SNP 
in a region. “Burden tests” that integrate over potentially causative SNPs may offer a 
solution, but although their development is an active area of research, it is a difficult 
statistical problem [22-24]. By contrast, in an MPP, the size of founder blocks is generally 
larger than a gene, so the k-way ANOVA carried out at each genomic position automatically 
considers the possibility of multiallelism. One possible explanation for both the missing 
heritability in humans [7], and the observation that QTL fine-mapped in MPPs generally 
explain much larger fractions of the genetic variation [17] than GWAS loci [25] is the 
failure of routine GWAS methods to account for the possibility of allelic heterogeneity at 
causative genes.
MPP Case Study: The Drosophila Synthetic Population Resource
We developed and distribute the Drosophila Synthetic Population Resource (DSPR; 
www.flyrils.org; [14,15]; Box 1), the largest MPP resource available for an animal model 
system. The initial mapping experiment employing the DSPR was a proof-of-principal study 
to empirically demonstrate its power and accuracy [14]. Pioneering work from Cathy Laurie 
and colleagues demonstrated that sites segregating at the Alcohol dehydrogenase (Adh) 
locus, in particular the Fast/Slow allozyme polymorphism, have a major effect on the 
observed activity of the ADH enzyme in vivo [26-28]. We measured ADH enzyme activity 
in all DSPR RILs, and mapped a large-effect QTL that implicated just 22 genes, including 
Adh. It is quite clear that ADH activity in the RILs is strongly correlated with the allele 
present at the nonsynonymous site underlying the Fast/Slow polymorphism. Because the 
founder haplotype means at the Adh-associated QTL do not clearly fall into just two groups, 
other sites in the region are additionally responsible for conferring some activity variation. 
One of these sites is likely to be the intronic ∇1 insertion/deletion event that influences the 
amount of ADH protein produced [27], along with at least one other functional variant 
predicted to reside at Adh [28].
In our ADH activity study, we were able to map a number of loci influencing the phenotype 
in trans. The existence of such loci was predicted [29] but they were not previously 
localized with any precision. Collectively, our single experiment was able to map eight QTL 
influencing ADH activity, explaining approximately 60% of the genetic variation for the 
trait. We have subsequently used the DSPR to map QTL explaining large fractions of the 
heritable variation for traits such as nicotine resistance [30], and the response to widely-used 
chemotheraphy drugs [31,32]. Several other groups are also using the DSPR to study 
additional metabolic, morphological, and behavioral traits (www.FlyRILs.org/Projects). 
These experiments have enjoyed success, routinely identifying QTL contributing >5% of the 
genetic variance, where the additive contribution of all mapped QTL explains a large 
fraction of the heritable variation. This stands is in stark contrast to the picture typically 
observed in human GWAS studies [7]. The haplotype-based tests used in an MPP such as 
the DSPR allow the sampled collection of causative sites at a gene to be tested as a group. 
Thus, while the effects of the individual causative sites might not be distinguishable, 
causative genes are powerfully-mapped using MPP. In a GWAS, small-effect causative sites 
at a gene are unlikely to reach genome-wide significance given the large number of SNPs 
tested and therefore go undetected [25].
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Empirical Estimates of Allele Number at eQTL
Transcript abundances of the vast majority of genes are complex traits with heritabilities 
comparable to visible phenotypes. We characterized the transcriptome in female head tissue 
using the DSPR, examining more than 11,000 transcripts in ∼600 genotypes [33]. 
Expression QTL (eQTL) mapping allowed us to describe the genetic architecture of 
thousands of complex phenotypes, potentially leading to general conclusions regarding the 
frequencies, numbers of alleles, and effect sizes of loci contributing to complex traits. In 
addition, a comprehensive map of the genetic variants underlying the expression of all 
transcripts in a specific tissue brings us closer to the ultimate goal of linking together 
variation at multiple organizational levels. Overall, we identified local, cis-eQTL for ∼70% 
of all transcripts. As observed in other eQTL studies, cis-eQTL have large effect sizes 
(median = 24% of phenotypic variation), but by no means explain all of the variance in 
transcript abundances. A substantial portion of the genetic variance remains undiscovered, 
presumably residing in multiple, small-effect trans variants.
A principal advantage of MPP designs is the ability to use a haplotype-based analysis to 
assess the extent of multiallelism. A major result of our study is the implication that the 
majority of eQTL are multiallelic, with founder genotype means falling into more than two 
allelic classes (Figure 2). We estimate three or more alleles are segregating for 95% of cis-
eQTLs, suggesting allelic heterogeneity may be the norm for complex traits. Other studies 
have also found evidence for multiallelism at the level of eQTLs in Drosophila [34], 
Arabidopsis [35], and humans [36,37], although not in mice [17]. Simply distinguishing 
between a biallelic model and any multiallelic model is relatively straightforward. However, 
estimating the number of alleles at a QTL and categorizing founder genotype means into 
allelic groups remains a significant analytical challenge. Our simulations suggest that when 
the actual number of alleles is greater than three, we are currently unable to accurately 
estimate the true value (Figure 2; [33]). This is due both to uncertainty in founder genotype 
mean estimation and possible shortcomings of model comparison methods.
Mapping Designs
When using a panel of MPP RILs, the experimental design to be employed is an important 
consideration. The simplest format is to directly phenotype the RILs (e.g., [14,30]), but this 
may be problematic for fitness-related traits, such as many behavioral and reproductive 
characters, that are expected to suffer from inbreeding depression. A second strategy is to 
phenotype the F1 of crosses between pairs of A and B RILs (e.g., [31,33]). This approach 
ensures an outbred, heterozygous set of experimental individuals. However, under this 
design there are 64 possible diploid genotypes at any given position, or 16 additive effects to 
estimate, so even when several hundred genotypes are examined parameter estimation can 
be a challenge. A third approach is to cross each RIL to a handful of inbred reference strains 
and phenotype the F1 [38]. This approach allows for more convenient parameter estimation 
as well as the potential to estimate background specific epistasis, so it holds considerable 
promise, although a more thorough empirical assessment is still required, and certain 
designs may be more or less powerful for particular traits and/or questions.
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From QTL to Causative Variants
Making the transition from statistically mapped QTL to the molecular genetic architecture of 
complex traits is the ultimate goal, and several avenues are available to accomplish this.
QTL Phasing
For QTL contributing >5% to standing variation, provided several hundred RILs are 
examined, both empirically-motivated simulations [15] and experiments suggest QTL can be 
resolved to intervals of 1-2 cM. This is considerably greater resolution than traditional QTL 
mapping, and in flies such intervals will typically implicate <50 genes, and often suggest 
clear candidates [14,30-32,39]. An appealing theoretical aspect of the DSPR is the idea of 
“phasing” mapped QTL, thereby reducing the candidate causative variant list to just a few 
dozen candidates. Phasing is based on the idea that at a QTL peak it is possible that the 
average phenotype associated with different founder genotypes falls into two distinct 
categories, each plausibly representing a single allelic state (as depicted in Figure 3a). When 
two clear classes present themselves, it is then possible to identify a handful of variants 
segregating among the founders that are “in-phase” with those means (Figure 3a). For large-
effect, apparently bi-allelic QTL, phasing has been empirically demonstrated to work. We 
used this approach to identify the Fast/Slow variant at Adh [14], and it has been successfully 
used in the collaborative cross to identify candidate causative SNPs [39]. If allelic 
heterogeneity exists then phasing has much less utility (Figure 3b). If, for example, the four 
odd-numbered founder alleles each associated with a low phenotypic value in Figure 3a are 
each due to an independent cis-regulatory mutation that partially abolishes expression, then 
phasing cannot be successfully used to identify candidate causative variants.
Moving forward, an important empirical question is what fraction of mapped QTL in the 
DSPR have a genetic architecture consistent with allelic heterogeneity as opposed to a 
simple biallelic inheritance. For the traditional traits studied to date, mapped QTL often do 
not appear to be bi-allelic. These observations are in agreement with the results of cis-eQTL 
mapping experiments where mapped QTL are also rarely biallelic. In concert, these 
observations suggest that the fraction of QTL segregating for several, as opposed to two, 
functional alleles may be large for many of the traditional morphological, physiological, and 
behavioral traits of interest to biologists. An implication is that statistical tests designed to 
detect genes harboring multiple causative SNPs in GWAS datasets may be more suited to 
uncovering the genetic basis of complex trait variation than the current, almost universally-
employed SNP-centric tests.
Leveraging Multiple Reference Populations
A second community resource for dissecting complex traits in Drosophila is the Drosophila 
Genetic Reference Panel (DGRP; [10,12]), a collection of roughly 200 unrelated, completely 
resequenced inbred lines. The approach to dissection with the DGRP is a GWAS, with some 
extra power obtained via the replicate phenotyping of inbred lines. As mentioned above, 
GWAS approaches are most successful in the case of an intermediate frequency biallelic 
SNP. For example, if there is a causative SNP at intermediate frequency contributing at least 
15% (7%) to the variation among line means the DGRP has a ∼75% (12%) chance of 
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detecting and localizing it (at α=10-6 to control the genome-wide false positive rate; see Box 
2). A potentially powerful approach would be to use the DGRP to validate QTL identified in 
the DSPR. If the DSPR can be used to narrow a candidate interval to 1-2 cM, a lower 
statistical threshold can be used in the DGRP, muting the problem of strict, genomewide 
correction for multiple testing. However, if QTL are generally multiallelic, localization 
using the DGRP will be challenging. Imagine a hypothetical gene that contributes 5% to 
standing variation, where the effect comes from four SNPs in linkage equilibrium, each 
contributing 1.25% to variation (see Figure 3b). The DSPR has excellent power to map and 
localize such a QTL (we estimate the power to map a QTL contributing 5% to the variance 
in line means given 600 RILs phenotyped is ∼90% [15]). However, because each SNP 
would have only a small effect, the DGRP is unlikely to validate them. We anxiously await 
the results of experiments that measure the same complex traits in both the DSPR and the 
DGRP and empirically determine the level of correspondence.
Functional Genomics
Historically the Drosophila complex trait community has used the binary GAL4-
UAS::RNAi system [40] to suggest a candidate gene is indeed causal. The premise is that if 
a phenotype changes between the control and the RNAi knockdown strains, one can be 
reasonably confident they have the correct gene. Such experiments have been fairly 
convincing when the knockdown is confined to a very precise tissue and/or temporal 
window, but perhaps less so when the knockdown is constitutive (e.g., an actin GAL4 
driver), or the UAS::RNAi construct may be reasonably expected to exhibit pleiotropy (e.g., 
when knocking down a transcription factor), or the trait of interest might be influenced by a 
range of genetic pathways (e.g., a behavioral or life history trait).
The ultimate proof of causation will require replacing a candidate gene region in an isogenic 
background - ideally multiple such backgrounds - with several different natural alleles. 
There is hope that the CRISPR-Cas9 system will make such precise genome editing routine 
[41], but such experiments will likely remain sufficiently laborious that it would seem 
prudent to identify a very strong candidate gene before embarking on such an experimental 
program. We believe two types of community data will greatly aid researchers in this regard. 
First, access to eQTLs for several tissues and developmental time points will be critical to 
the resolution of candidate genes under complex trait QTL. There is much speculation that a 
large fraction of variation in complex traits is ultimately regulatory in origin [42-44], and a 
cis-regulatory eQTL that overlaps a QTL for a trait, and where there is a strong correlation 
among the founder effects at the two mapped loci, would represent strong evidence for the 
target gene making a regulatory contribution to trait variation. Second, given the important 
role of chromatin accessibility in gene regulation, and the strong association between eQTL 
and DNase I-hypersensitive sites [45,46], we suggest that maps of DNase I sensitivity QTL 
(dsQTL) for a range of tissues or timepoints would represent a valuable resource for 
investigators dissecting complex traits to the level of variants in transcription factor binding 
sites.
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Lessons from Model Systems
The DSPR, and similar frameworks available in other model systems, are critical for 
research into the genetic basis of complex, biomedically relevant traits. In both model 
systems and human populations, identifying the genes responsible for complex trait 
variation implicates new genes and new pathways in the control of trait variation. By 
leveraging the battery of tools available, model systems have the potential to go beyond 
what is possible in human populations, dissecting the fundamental properties of trait 
architecture at a mechanistic, functional level. Current and forthcoming projects using the 
DSPR, and work on mammalian MPPs, consistently demonstrate high mapping power, and 
often map QTL contributing much greater fractions of the genetic variation than do GWAS 
studies in human populations. An interesting observation that has already arisen from animal 
MPPs is that mapped QTL can fail to exhibit segregation patterns indicative of simple 
biallelic inheritance [17,33]. Instead, patterns are suggestive of the multiallelism typically 
found at genes underlying Mendelian disorders, merely with a significant reduction in 
penetrance of the individual causative variants. If multiallelism is also common at complex 
trait-associated genes in humans, as has been suggested (cf. [47]), one plausible contributor 
to the missing heritability problem is the failure of typical human GWAS analysis to 
explicitly consider this allelic heterogeneity [22]. If multiple, small-effect causative 
mutations are present at a trait-associated gene, especially if they are relatively rare and on 
different haplotypes, SNP-by-SNP testing will fail to tag these variants in a single test, and 
fail to identify all but the largest associations. One major lesson for human GWAS from 
studies in model systems is to prioritize developing analytical approaches designed to detect 
multiallelic causative genes. Over the next decade, multiparent advanced intercross 
resources such as the DSPR are likely to uncover other general lessons that can aid in the 
dissection of complex traits in humans.
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Characteristics of the Drosophila Synthetic Population Resource
The DSPR is derived from two synthetic populations of D. melanogaster, populations A 
and B, each derived from a set of eight founders (seven of the founders are unique to a 
population, while one founder is shared by both A and B). The synthetic populations 
were created by mass-mating trans-heterozygotes obtained from a series of round-robin 
crosses within a set of eight founders (Figure 1). The populations were immediately split 
into two pairs of subpopulations (A1, A2, B1, and B2) and the subpopulations maintained 
for an additional 50 generations of mass mating at an estimated census population size of 
500-2000 individuals. At generation 50 we established ∼2500 brother-sister lines that 
were subsequently inbred for 25 generations via full-sib mating to obtain ∼1700 RILs 
divided roughly equally between the four synthetic subpopulations. The DSPR is highly 
powered to detect QTL by virtue of the large number of RILs available [15]. All 15 
founder lines were Illumina resequenced using paired end reads to roughly 50×, allowing 
the identification of virtually every SNP segregating between the RILs in non-repetitive 
parts of the genome. We have since also identified 7,104 transposable elements 
segregating in the founders [48], and this data is part of the current release (Release 3; 
www.FlyRILs.org). Each of the RILs were genotyped using RADseq [14,49] to obtain 
roughly 10K SNP markers. As the SNP density achieved using RADseq was denser than 
the average size of a recombinant fragment, we were able to construct a Hidden Markov 
Model (HMM). For any given RIL at any given location in the genome, the HMM 
confidently estimates the probability it harbors material derived from each of the 8 
possible founders [14].
The number of generations of recombination in an MPP before initiating RIL creation 
results in a trade-off between founder representation and mapping resolution. The DSPR 
underwent 50 generations of mass mating in large population cages. This method of 
creating mosaic genomes via free recombination is contrasted with the three generation 
fixed funnel mating scheme utilized by the Collaborative Cross (Figure 1). There are 
advantages and disadvantages to both approaches. The mass mating strategy results in 
shared recombination events between lines, with early recombination events being 
represented in a larger number of lines. In addition, during the mass-mating phase, both 
selection and drift can act on the populations, leading to uneven founder representation in 
the panel [14]. The Mouse Collaborative Cross panel does not share these features, by 
virtue of their use of the fixed funnel crossing design [50]. Despite the disadvantages of 
50 generations of free recombination there is a major advantage – increased mapping 
resolution. In the DSPR, recombinant segment sizes average just 3cM and QTL are 
typically mapped to ∼1-2cM.
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Power to Detect a Causative Variant Contributing to a Continuous Trait in a 
Collection of Inbred Lines
We set up a simple simulation model to determine the expected power to detect a single 
causative variant in a panel of 200 inbred lines. We simulated a single SNP at a 
frequency of 33% that contributed either 7% or 10% to the variance between line means. 
We then generated the remaining variance from a normal distribution to simulate a 
phenotype for each line. We obtained a p-value for each simulated SNP using a t-test. To 
control the false positive rate given the roughly 3 million expected tests for a genome 
scan, we used a significance threshold of p = 1e-6. This simulation was performed 1000 
times and the power is the resulting proportion of significant tests. The code to reproduce 
this simulation is below. The code can be easily modified to consider different allele 
frequencies for the causative site, difference thresholds for significance, and different 
percent variance between line means explained by the causative site.
#### R code ####
# Assume:
# a) 200 Inbred Lines are available
# b) Causative SNP at a frequency of 33%
# c) Causative site contributes 7% or 10% of the
# variance between line means. This translates to 3.5% or
# 5% of Vt if the trait's hˆ2 is 50%.









for (i in 1:1000){
Y <- I + rnorm(200,0,sqrt(vE))
df <- data.frame(Y=Y,I=I)
out <- t.test(Y∼I,data=df)
hit <- hit + (out[[3]] < alpha)
}
cat(“%Var Line Means=”,PerVar, “\t”,“Power=”,hit/10, “%\n”)
#################
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Some common advanced intercross resources highlighting different crossing schemes. The 
Drosophila Synthetic Population Resource (DSPR) generates an F1 using a “round-robin” 
crossing scheme between the 8 highly inbred founder strains. The F1 are then randomly 
mated for 50 generations to maximize recombination, and RILs generated by 25 generations 
of sibling mating. The DSPR involved two parallel crossing schemes each initiated from a 
different set of 8 founders. The Mouse Collaborative Cross (CC) also starts with 8 highly 
inbred founders, but mates them using a 3 generation “funnel” cross, followed by roughly 17 
generations of brother-sister mating of sub-lines. The CC achieves more even founder 
representation than the DSPR, at the expense of the size of recombinant fragments. The 
Nested Association Mapping (NAM) resource of maize starts with 25 inbred founders, but 
crosses each founder to a common parent (B73) to create 25 highly recombined populations. 
Unlike the CC and DSPR where 8 chromosomes are segregating in a panel, in NAM only 2 
chromosomes segregate in each of the 25 panels.
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Density plot of the estimated number of alleles over replicate simulations under models 
where the true number of alleles (different colored lines) take on different values. Also 
plotted (thick black line) is the observed distribution of the number of estimated alleles over 
all detected cis-eQTL. The observed data most closely matches the distribution of the 
simulated data when QTLs segregate 5 alleles (pink line).
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A) A simulated set of founder means for a QTL explaining 5% of the variance in a set of 
RILs. Underlying the QTL is a single biallelic SNP, with the low allele present in odd-
numbered founders and the high allele present in even-numbered founders. Error bars are 
SEMs based on 80 RILs per founder allele at the location of the mapped QTL. The plot 
suggests an underlying biallelic architecture. In the case of a single intermediate frequency 
causative site the number of “in phase” SNPs is quite modest. For example, for a biallelic 
causative site with the high allele present in 4 out of 8 founders localized to 1.5cM the 
expected number of candidate causative SNPs is <10. B) The scenario in which the four low 
alleles of panel A are not due to a single minor allele, but four independent rare cis-
regulatory alleles all in the same gene. Such allelic heterogeneity is expected under a 
mutation-selection balance model. Under this model each causative SNP only explains ∼1% 
of the variation between line means. Furthermore, causative SNPs that are private in the 
DSPR are likely rare in the population as a whole or in a resource like the DGRP. Such 
causative SNPs are extremely difficult to detect using a GWAS approach as they are both 
rare and of subtle effect.
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